Adverse effects of posterior lumbar interbody fusion using rhBMP-2.
Tomislav
T
Smoljanovic
Ivan
I
Bojanic
Domagoj
D
Delimar
D000818:Animals; D055396:Bone Morphogenetic Protein 2 / Q000008:administration & dosage / Q000009:adverse effects*; D001862:Bone Resorption / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000009:adverse effects / Q000706:statistics & numerical data; D003094:Collagen / Q000009:adverse effects; D004195:Disease Models, Animal; D005548:Foreign-Body Migration / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D016268:Internal Fixators / Q000009:adverse effects; D007405:Intervertebral Disc Displacement / Q000601:surgery; D008159:Lumbar Vertebrae / Q000473:pathology / Q000601:surgery*; D011183:Postoperative Complications / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D019736:Prostheses and Implants / Q000009:adverse effects; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D013123:Spinal Fusion / Q000009:adverse effects* / Q000379:methods; D015503:Surgical Sponges / Q000009:adverse effects
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D011994:Recombinant Proteins; D003094:Collagen